Tbe alpha/beta (type I) interferon-inducible human MxA protein confen resistance to vesicular stomatitis virus (VSV) and inßuenza A virus in MxA·transfected mouse 3T3 cells (31'3/MxA). We investigated the inhibitory etfects of the MxA protein on measles virus (MV) and VSV in the human monocytic cell line U937. In transfected U937 clones which constitutively express MxA (U937/MxA), the release of infectious MV and VSV was reduced approximately 100-fold in comparison with control titers. Transcription of VSV was inhibited similar to that observed for 3T3/MxA cells, whereas no ditference was detected for MV in the rates of transcripdon or the Ievels of MV -specific mRNAs. In contrast, analysis of MV protein expression by immunoßuorescence and immunoprecipitation revealed a significant reduction in the synthesis of MV glycoproteins FandHin U937/MxA cells. These data demoostrate a virus-specific etfect of MxA which may, in the case of MV, contribute to the establishment of a penistent infection in human monocytic cells.
Tbe alpha/beta (type I) interferon-inducible human MxA protein confen resistance to vesicular stomatitis virus (VSV) and inßuenza A virus in MxA·transfected mouse 3T3 cells (31'3/MxA). We investigated the inhibitory etfects of the MxA protein on measles virus (MV) and VSV in the human monocytic cell line U937. In transfected U937 clones which constitutively express MxA (U937/MxA), the release of infectious MV and VSV was reduced approximately 100-fold in comparison with control titers. Transcription of VSV was inhibited similar to that observed for 3T3/MxA cells, whereas no ditference was detected for MV in the rates of transcripdon or the Ievels of MV -specific mRNAs. In contrast, analysis of MV protein expression by immunoßuorescence and immunoprecipitation revealed a significant reduction in the synthesis of MV glycoproteins FandHin U937/MxA cells. These data demoostrate a virus-specific etfect of MxA which may, in the case of MV, contribute to the establishment of a penistent infection in human monocytic cells.
The interaction of measles virus (MV) with peripheral blood mononuclear cells (PBMCs) in acute measles is of pathogenetic importance since this virus not only replicates in these different cell populations (19, 30, 45) but also alters their function (25) . In particular, the immunosuppression that accompanies acute measles, and contributes to opportunistic infections which account for most of the morbidity and mortality associated with measles, is of interest (8, 25) .
It is evident that these effects are in part dependent on the replication strategy of the virus as weil as on host factors. So far, the mechanisms by which MV interferes with PBMC functions are unknown. · During acute measles, MV can be isolated from PBMC fractions of patients (22, 37) , whereas after disease recovery infectious MV has disappeared (22, 27, 37, 38) . Only occasionally is it possible to demoostrate the presence of MV in PBMCs of healthy donors who have previously experienced acute MV infections, suggesting a state of viral persistence (3, 13, 36) . In tissue culture experiments, productive as weil as silent MV infections have been observed in PBMCs, depending on the activation stage of the ceils, providing evidence of a direct influence of cellular factors in MV replication (6, 25) . In lymphocytes, for example, MV can replicate only after these cells have been stimulated by a mitogen, whereas in unstimulated ceils MV RNA persists. Subsequent Stimulation of infected lymphocytes Ieads to viral replication without lymphocyte proliferation and differentiation (6, 8, 19, 25) . For permanent celllines of lymphocytic origin, a lytic infection, as weil as the establishment of persistent infections, has been described, allowing the investigation of cellular factors contributing to MV persistence (5, 9, 21).
The observed downregulation of MV multiplication in PBMCs appears to be mediated by cytokines that are in-
•· Corresponding author. 4760 duced upon infection. In particular, type I interferon (IFN) has been shown tobe released from MV-infected PBMCs (20) and, more recently, to interfere with MV replication in these cells (24) . In response to IFN, a variety of IFNinducible proteins with different antiviral activities are produced, but it is not clear which of these interferes with MV gene expression. In other virus-host cell systems, the human cytoplasmic MxA protein, an IFN-inducible protein, has been shown to restriet the replication of vesicular Stomatitis virus (VSV) and influenza A virus in stably transfected mouse 3T3 cells. In the case of VSV infection, a downregulation of primary transcription occurred, whereas a later step of viral replication was blocked in influenza virusinfected cells (32, 43) .
Since the MxA protein has been shown t~ be expressed to high Ievels in monocytes following IFN treatment in vivo (44), we analyzed the in vitro replication of MV in comparison with that of VSV in an MxA-expressing stably transfected human mononuclear cell line, U937. Production of infectious virus particles was blocked by approximately 2
Iogs for MV and VSV in MxA-expressing U937 cells compared with nonexpressing cells. However, in contrast to VSV, MV -specific transcription was not altered in the presence of MxA. Analysis of protein expression showed the synthesis of MV -specific glycoproteins F and H to be inhibited, indicating that the mechanism of MxA-mediated restriction of MV gene expression occurs at a posttranscriptionallevel. These data suggest that MxA-dependent specific inhibition of glycoprotein expression may contribute to the establishrnent of measles virus persistence in PBMCs.
MATERIALS AND METHODS
Celllines, viruses, IFNs, and antibodies. The human histocytic Iymphoma ceil line U937 was grown in RPMI 1640 containing 10% fetal calf serum, 2.0 g of NaHC0 3 per Iiter, 0.1 g of penicillin per Iiter, and 0.1 g of streptomycin per VoL. 67, 1993 Iiter. For the human B-eeil line BJAB, this medium contained in addition 1 mM sodium pyruvate, 1 x nonessential amino acids, 1 x Eagle basal medium vitamins, and 2 mM L-glutamine (all from Seromed). Vero (African green monkey kidney) cells were grown in minimal essential medium supplemented with 5% fetal calf serum. Stocks of measles virus, Edmonston strain, were prepared from infected Vero cells. Stocks of VSV, serotype Indiana, were prepared from infected Swiss mouse 3T3 cells as previously described (12) . Recombinant human alpha interferon (IFN-a) and beta interferon (IFN-ß) were obtained from Merck. The p68 antibody was a generaus gift from G. Barber. For immunoprecipitation, a measles-specific human serum with a hemagglutination inhibition titer of 1:1,024 was used.
Plasmid construction and transfection. The entire coding sequence of the human MxA genewas excised by a Smal digest of pHG327/MxA (1). The 2.2-kb MxA fragmentwas cloned into the blunt-ended BamHl site of the expression vector pHß APr-1-neo (15) containing the human ß-actin promoter, generating the vector pHß APr-1-neo/MxA. U937 cells were transfected with this construct by the lipofectin method in accordance with the manufacturer's instructions (GIBCO/BRL). For selection, cells were cultured in the presence of 1 mg of G418 permland examined for MxA expression after 4 weeks by immunoftuorescence. Transfectants were cloned by limiting dilution and assayed for MxA expression by immunoftuorescence and Western blot (immunoblot) analysis.
Titration. A total of 10 6 U937 cells or U937 /MxA transfectants were infected with 10 7 PFU of MV or VSV at 37°C for 1 h. The virus inoculum was removed by centrifugation, and infected cells were incubated at 37°C for the time intervals indicated. Tenfold dilutions of the supematants were analyzed on Vero cells by endpoint titration after 3 or 4 days of incubation.
RNA analysis. A total of 10 7 U937 cells or U937/MxA transfectants were infected with MV at a multiplicity of infection (MOl) of 1 for 4 days. Cells were lysed in 4 M guanidinium isothiocyanate buffer, and RNA was purified by centrifugation through a CsCl cushion as described previously (11) . A total of 30 JJ.g of total RNA samples and 1 Jl.g of pA + Vero control RNA, which was enriched by 1 cycle of oligo(dT)-cellulose chromatography (Sigma), was analyzed by quantitative Northem (RNA) blot assay as described earlier (39) . Briefty, RNA was separated on a 1.5% agarase gel containing formaldehyde. After blotting onto nitrocellulose, filters were cut into strips and hybridized to strandspecific, [ 32 P)CTP-labelled RNA probes specific for the MV genes N, P, M, F, and H. The concentrations of the added synthetic standard RNAs were as follows: N, 13 fmol; P, 7 fmol; M, 7 fmol; F, 10 fmol; and H, 5 fmol.
For the in vivo [ lysed at the indicated time points, and RNA preparation and analysis were performed as described above.
For experiments with VSV, U937 /MxA cells were infected at 37°C with VSV at an MOl of 5 PFU per cell. Following removal of the inoculum, the cells were further incubated in growth medium at 37°C. At 3 h postinfection, cells were harvested and RNA was prepared as described by Chomczynski and Sacchi (12) . Experiments with cycloheximide (CHX) required that cells be pretreated with CHX at a concentration of 25 .,a.g/ml for 30 min before infection and kept in growth medium containing 25 J.Lg of CHX per ml for the duration of the whole experiment. The RNA preparations were analyzed for the presence of VSV N and L mRNAs by the Northem blotting technique as described earlier (38) . The hybridization probes were the HindiiiEcoRI fragment of plasmid pGN2 (14) , for detection of N mRNA, and an equimolar mixture of the 1,200-and the 1,400-bp Pstl fragments of plasmid pLH661 (42) , for detection of L mRNA.
lmmunofluorescence and flow cytometry. For total cell staining, 5 x lOS cells were fixed with 3.5% formaldehyde in phosphate-buffered saline (PBS) for 30 min and permeabilized in PBS containing 0.25% Triton X-100 for 10 min at room temperature. After being blocked for 15 min in washing buffer (PBS without Mg2+ and Ca 2 +, containing 0.4% bovine serum albumin and 0.02% sodium azide), the cells were incubated for 1 h with the specific antibody and, after three washing steps, incubated for a further hour with the second antibody (goat anti-mouse phycoerythrin; Dianova). All steps were carried out at room temperature. Cells were analyzed in a ftuorescence-activated cell scanner (FACScan; Becton Dickinson).
For surface immunoftuorescence staining, cells were fixed for 5 min without permeabilization and incubated with the appropriate antibodies for 30 min on ice.
Immunoprecipitation. Pulse-chase experiments were made with 2 x 10 6 cells infected with MV at an MOl of 1 for 15 h. Cells were starved for 30 min in methionine-free medium before 0.2 mCi of [ 35 S)methionine was added. Labelling was performed for 3 h, and cell extracts were prepared by Iysis in RIPA detergent (150 mM sodium chloride, 10 mM Tris, 1% deoxycholic acid, 1% Triton X-100, 1% sodium lauryl sulfate [SDS], 10 mM phenylmethylsulfonyl ftuoride). Equal amounts of protein were immunoprecipitated with human hyperimmune serurn and separated by SDS-10% polyacrylamide gel electrophoresis (PAGE). Pulse-labelling of infected cells was performed as described above except for an increase in the pulse-labelling period to 5 h. Lysates were immunoprecipitated with either human hyperimmune serum or a monoclonal antibody against the MV H protein.
Western blot analysis. Cell extracts were prepared as described above in RIPA detergent. A total of 10 JJ.g of total cell extracts was separated on 10% PAGE and transferred to nitrocellulose filters with a semidry blotter. Western blots were immunostained with a monoclonal anti-human MxA antibody or an anti-human p68 antibody. A peroxidaseconjugated rabbit anti-mouse immunoglobulin was used as the second antibody and developed with the enhanced chemiluminescence (ECL) system (Amersham).
RESULTS
MxA expression is not inducible in tbe human monocytic cell line U937. To assess the inducibility of MxA, the monocytic cell line U937 and the B-cell line BJAB were treated exogenously with 1,000 U of IFN-ß per ml or infected with MV at an MOl of 1 for 48 h. Whole-cell protein extracts were prepared and analyzed for the expression of the 78-kDa MxA protein by Western blotting (Fig. 1A) . In BJAB cells, MxA was induced by both IFN-~ (Fig. 1A , lane 2) and infection with MV (Fig. 1A, lane 3) . However, in protein extracts of U937 cells no MxA-specific signals could be detected (Fig.  1A, lanes 4 to 6) . In contrast to the inability to detect MxA protein, expression of a second IFN-inducible gene, p68, was clearly stimulated in U937 cells by IFN treatment (Fig.  18 , lanes 2 and 3) or viral infection (Fig. 1B, lanes 4 and 5) . This indicates that the inability of U937 cells to express MxA was specific for this particular protein rather than reflecting a generat defect in the IFN pathway of these cells.
Stably transfeded U937 ceUs expressing MxA protein. The 2.0-kb Smal cDNA fragment containing the entire coding region for the MxA protein, but lacking 397 nucleotides of the 3' untranslated 450-bp sequence, was cloned into the multiple cloning site of plasmid pH~ APr-1-neo between the ~-actin promoter and the polyadenylation sequence as described in Materials and Methods. In addition, the vector contained a neomycin resistance gene driven by the siQ'lian virus 40 promoter as a selection marker. Following lipofection, stably transfected U937 cells were selected in medium containing G418 for a period of approximately 4 weeks, after which surviving cells were cloned by limiting dilution. Nine independent cell lines were obtained after 7 weeks and continuously cultured in the selection medium. The U937 cell clones were assayed for MxA expression by immunofluorescence staining and subsequent flow cytometry analysis. As shown in Table 1 , all clones, with the exception of clone 8, expressed high Ievels of MxA protein. The mean fluorescence intensity in these populations was comparable to the intensity for infected BJAB cells which were used as a control (data not shown). Clone 8 did not express MxA and was therefore used in addition to the nontransfected cellline as a negative control for the following experiments. Expres-J. VIROL. sion of MxA remained stable for all U937 /MxA clones for more than 1 year.
VSV and MV multiplication in stably transfected U937/MxA clones. To test the biological activity of the transfected MxA gene, the multiplication of VSV in U937 clones expressing MxA was compared with that in the parental cellline. Cells were infected at an MOl of 10 and supematants were harvested after 24 h and titrated on Vero cells. In control cells, VSV replicated to a titer of 10 7 PFU/ml; however, in the transfectants VSV titers were reduced, indicating a reduction of at least 30-to 100-fold. This was comparable to the data described for 3T3/MxA cells (Table 2 ) (33) . By repeating the experiment under the same conditions with MV, essentially the same results were obtained, with titers of infectious MV released after 48 h from U937 MxAexpressing clones being significantly lower than those of the nonexpressing control cells (Table 2) .
MV -specific transcription in transfeded and nontransfected U937 cells. Since the inhibition of primary transcription of VSV genes has been described for 3T3/MxA cells (43), MV -specific transcription in U937 cells and the MxA-transfected celllines was analyzed. Vero cells were included as additional controls. Cells were infected with MV at an MOl of 1; total RNA was prepared after 48 h and assayed for the expression of the monocistronic MV -specific transcripts by quantitative Northern blotting (Fig. 2) . Signals specific for N-, P-, M-, F-, and H-specific monocistronic transcripts and the corresponding synthetic Standard RNAs were quantitated, and the transcription gradients were determined in 
The data result from two independent experiments. b A total of 1lf cells were infected with MV for 2 days at an MOl of 10 and cultivated in 1 ml of medium. Supernalants were analyzed in 10-fold dilutions on Vero cells in endpoint titration assays.
c Cells were infected witb VSV at an MOl of 10 for 24 h. and supematants were analyzed as described above. Fig. 2A and B) , untransfected U937 cells showed a significantly steeper transcription gradient, characterized by a low abundance of all monocistronic MV-specific transcripts downstream of the N gene ( Fig. 2A  and C) . Comparison of the amounts of MV-specific transcripts in the MxA-expressing U937 clones 5 and 6 ( Fig. 2D and E) and in untransfected control cells revealed no significant differences ( Fig. 2A, C, D , and E). The same results were obtained with U937/MxA clone 8 as the negative control (data not shown). In order to exclude the possibility that transcriptional downregulation was missed because of the accumulation of viral transcripts during the 48 h of infection, pulse-labelling of the viral RNAs in the presence of ( 32 P]Pi was performed for U937 clones 5, 6, and 8. As shown in Fig. 3A , considerable amounts of all MV-specific transcripts were produced. For clones 5 and 6 (Fig. 3A, lanes  1 and 2) , which both expressed high Ievels of MxA, again no differences from the control cells were observed (Fig. 3A,  lane 3) .
To assess the stability of MV -specific transcripts, a pulsechase experiment was performed for MV-infected Vero, U937, and U937/MxA clone 5 cells (Fig. 3B) . The rate of synthesis of MV -specific transcripts in U937 cells was generally lower than that in Vero cells during the 90-min
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pulse-labelling period (Fig. 3B, lanes 4 and 7) . No differences in the stability of the viral transcripts were observed for infected U937 /MxA transfectants (Fig. 3B, lanes 1 Fig. 4 (Fig. 4, N) . Similar results were obtained for the accumulation of P and M proteins (data not shown). In contrast, the expression of the viral glycoproteins F and H was significantly reduced at the surface of U937 /MxA cell clones 5 and 6 compared with the nontransfected cells and U937 /MxA clone 8, which does not express MxA. As an example, the immunoftuorescence intensity for clone 5 in comparison to clone 8 is reduced on average by 1log (Fig. 4, F and H) . The considerably reduced expression of the viral glycoproteins in MxA-expressing U937 cells was confirmed by performing indirect immunoftuorescence staining of MV F and H in permeabilized cells. In order to determine whether or not the restricted accumulation of the glycoproteins was due to their reduced stability, U937 /MxA clones 5 and 8 were infected with MV at an MOl of 1 for 15 h, pulse-labelled with (
35 S]methionine for 3 h, and subsequently chased for the time intervals indicated (Fig. 5) . MV-specific proteins were immunoprecipitated with human hyperimmune serum (Fig. 5, lanes 1 to 8) . As in Fig.  4 , no differences in N-protein expression between the cell clones were seen (Fig. 5, lanes 1 and 5) , whereas the H-protein synthesis in U937/MxA clone 5 was reduced, in comparison with that in U937 /MxA clone 8, at each time point tested (Fig. 5) . In contrast, no differences in stability were observed for N and H proteins in U937 clone 5 and clone 8 cells (Fig. 5, lanes 1 to 8) .
In order to assess differences in the rate of synthesis of MV glycoproteins, U937 clones 5, 6, and 8, plus the untransfected U937 cells, were infected as described in the previous experiment. Pulse-labelling was performed for 5 h, beginning at 15 h postinfection, and MV -specific proteins were immunoprecipitated with human hyperimmune serum (Fig. 6 , lanes 1 to 4) or a monoclonal antibody against H (Fig. 6,  lanes 5 to 8) . Precipitation with human hyperimmune serum against MV revealed that the synthesis of N protein was not significantly different in U937 clones 5 and 6 compared with clone 8 and the untransfected control (Fig. 6, lanes 1 to 4) . In contrast, the synthesis of H proteinwas strongly reduced in clone 5 cells and less, but still somewhat, significantly reduced in clone 6 cells compared with the controls (Fig. 6,  lanes 1 to 4) . This finding was confirmed with the monoclonal anti-H antibody (Fig. 6, lanes 5 to 8) . Therefore, we reinvestigated the MxA expression of clone 6 cells. A considerable loss of the mean expression Ievel of MxA was observed, which most probably accounted for the lesser ability to downregulate H protein synthesis compared with that of clone 5 (Fig. 6, lanes 6 and 7) .
Our data indicate that the primary target for the regulation of MV gene expression by MxA may be a specific inhibition and RNA accumulation could be due to direct interference with either VSV mRNA or protein synthesis. To distinguish between primary transcription of the parental viral genome and transcription of the amplified viral genome, which depends on ongoing translation, we carried out a parallel experiment in the presence of the protein synthesis inhibitor CHX. The optimal concentration of CHX to achieve minimal cytotoxicity with inhibition of protein synthesis by more than 95%, as determined by (
35 S]methionine incorporation, for our celllines was 25 ...,glml. CHX (25 J.Lg/ml) was added to each culture 30 min before infection, and this concentration was maintained throughout the experiment. As shown in 
0\. 0\. 0\ The mechanism for the obsetved restriction of viral glycoprotein expression appeared to act on steps later than transcription, because it was shown that synthesis and stability of the corresponding mRNAs were unaffected ( Fig.  2 and 3) . Unfortunately, the translational activity of these mRNAs could not be tested in vitro. First, the corresponding mRNAs are expressed to relatively low copy numbers, and second, the proteins synthesized in vitro are not detected because the glycoprotein-specific antiborlies are directed against the glycosylated protein. The possibility that MxA interferes with the processing of the mRNAs for F and H is unlikely since comparable amounts of H protein were detected in both U937/MxA cells and the control cells by short-time-labelling experiments (Fig. 5) . In addition, it is difficult to envisage that defects in mRNA maturation would be selective for F-and H-specific transcripts alone. For the same reason, alterations of the secondary structure that might impair the translational efficiency (23) are not anticipated. Whereas for the F-specific mRNA secondary structures were proposed because of the 582-nucleotide-long 5' nontranslated region (35) , the H mRNA does not differ from the other MV -specific mRNAs in having just a few nucleotides preceding the coding region (2) . However, it is remarkable to note in this context that specific translational inhibition of MV M and F mRNAs has been described with elevation of the temperature (28, 29) . The finding that the antiviral activity of Mx proteins can be posttranscriptional is not unprecedented (26, 32) . In stably MxA·transfected 3T3 cells, the multiplication of inftuenza A virus proved to be inhibited at a stage later than primary transcription. Maturation and transport of the primary transcripts were unaffected. In that study, the inhibition of viral protein expression was highly pronounced for the larger structural proteins whereas the synthesis of M and NS was merely affected (32) . Because of the fact that most of the MV -specific structural proteins, except M and L, are of comparable sizes, it is difficult to relate the translational restrictions to the size of the corresponding proteins. Although we were unable to determine the expression of L protein, because of its low expression Ievels and the Iack of appropriate antibodies, we would not expect this protein to be reduced because transcription of MV -specific mRNAs appeared unaltered qualitatively and quantitatively in MxAexpressing U937 cells.
Our data indicate that the antiviral effect on VSV replication by MxA in U937 cells was directed at the Ievel of viral RNA synthesis. As described previously for mouse 31'3/ MxA cells (43) , synthesis of VSV primary transcripts was severely inhibited in U937/MxA cells (Fig. 7) . Consequently, VSV proteins accumulated to Ievels barely detectable in U937/MxA cells (data not shown). However, it cannot be ruled out that an additional translational regulation may be imposed on these mRNAs.
Our data confirm that the MxA-dependent inhibition of VSV synthesis in 3T3 and U937 cells is independent of the host cell. However, the inhibitory activity of MxA in human J. VIROL. U937 cells is clearly virus specific. At present, this discrep· ancy cannot be explained since the mode of action of Mx proteins has not been defined on a molecular Ievel. The GTPase activity of Mx proteins appears to be directly correlated with their antiviral activity (31) . In addition, since they do not have RNA or DNA binding activities, Mx proteins may act via direct protein·protein interactions (16) . The inhibitory effect of Mx1 on inftuenza A virus multipli· cation could be partially titrated by the overexpression of PB2. However, a direct interaction of Mx proteins with viral components could not be found (18) . Alternatively, weak physical interactions of MxA protein with actin and tubulin, both components of the cytoskeleton, have been demon· strated (17) . In this context, it is interesting to note that the association of mRNAs with the cytoskeletal framework has been show to play a role in governing translation of viral as weil as cellular mRNAs (10) . Since translation of mRNA coding for glycoproteins requires specialized cellular com· partments, one could envisage that MxA in U937 cells might act by interfering specifically with transport of MV RNAs to, or their translation at, the rough endoplasmic reticulum. A general effect on the expression of cellular surface proteins cannot be overlooked but was not detected in our experiments (data not shown).
In our experimental system, the human monocytic cellline U937 does not express endogenaus MxA. Although the general pathway for IFN stimulation did not appear to be defective (Fig. 1B) , it has been shown that in vivo mono· cytes exhibit very high Ievels of MxA, up to eightfold higher than those in T or B cells, upon exogenaus IFN treatment (16) . During acute infection, MV infects predominantly PBMCs accompanied by the production of type I IFN (19, 34) . Type I IFN, as weil as MV infection, also Ieads to the induction of MxA in PBMCs in vitro. Because of the inhibitory action of MxA an MV glycoprotein synthesis, a powerful mechanism is provided for the establishment of a persistent infection in monocytic cells by a direct interference with virus replication in MxA-expressing cells, accompanied by a reduction in the release of infectious virus. As shown by our experiments, this effect is directly dependent on the expression of MxA rather than additional IFNinducible proteins, since comparable amounts of IFN are induced in MxA-expressing and nonexpressing U937 cells following MV infection, as indicate9 by the expression of p68 (Fig. 1B) . In addition, following exogenaus IFN treatment, no synergistic effects on the inhibition of MV replication in either cell type could be observed (data not shown).
MV is the causative agent of subacute sclerosing panencephalitis and measles inclusion body encephalitis. In both diseases, the occurring MV persistence in brain cells is characterized by particular transcriptional and translational defects (7, 41) . It has been observed that, during the establishment of persistent MV infections, factors intrinsic to the neural cells provide regulatory mechanisms restricting viral gene expression (4, 39)~ Among those, transcriptional downregulation leading to steep transcription gradients for the monocistronic MV-specific mRNAs has been described (39, 40) . In accordance with those findings, we have observed a similar transcription pattern in primary infected monocytic U937 cells (Fig. 2) . Transcriptional downregulation of MVspecific mRNAs tagether with an MxA-dependent specific inhibition of glycoprotein expression renders monocytes prime candidates for the establishment of persistent MV infections in PBMCs. Further experiments will help in the elucidation of the molecular mechanisms underlying these particular cell-type-specific regulations of MV.
